Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
Guarneri V, Frassoldati A, Ficarra G, Puglisi F, Andreetta C, Michelotti A, Cresti N, Boni C, Bisagni G, Berardi R, Battelli N, Santoro A, Banna G, Bottini A, Di Blasio B, Maiorana A, Piacentini F, Giovannelli S, Jovic G, Conte P. Guarneri V, et al. Among authors: di blasio b. Breast Cancer Res Treat. 2008 Jul;110(1):127-34. doi: 10.1007/s10549-007-9688-3. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687648 Free article. Clinical Trial.
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G, Di Blasio B, Boni C, Bisagni G, Ceci G, Rondini E, Bella M, Leonardi F, Savoldi L, Camisa R, Bruzzi P. Cocconi G, et al. Among authors: di blasio b. Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678. Cancer. 2002. PMID: 12124820 Free article. Clinical Trial.
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Cocconi G, Bisagni G, Ceci G, Di Blasio B, De Lisi V, Passalacqua R, Zadro A, Boni C, Morandi P, Savoldi L. Cocconi G, et al. Among authors: di blasio b. Breast Cancer Res Treat. 1999 Jul;56(2):125-32. doi: 10.1023/a:1006246012448. Breast Cancer Res Treat. 1999. PMID: 10573105 Clinical Trial.
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Cocconi G, Di Blasio B, Boni C, Bisagni G, Rondini E, Bella MA, Leonardi F, Savoldi L, Vallisneri C, Camisa R, Bruzzi P; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy. Cocconi G, et al. Among authors: di blasio b. Ann Oncol. 2005 Sep;16(9):1469-76. doi: 10.1093/annonc/mdi278. Epub 2005 Jun 14. Ann Oncol. 2005. PMID: 15956038 Free article. Clinical Trial.
Cisplatin and etoposide in advanced colorectal carcinoma.
Passalacqua R, Bisagni G, Cocconi G, Boni C, Di Blasio B, Ceci G. Passalacqua R, et al. Among authors: di blasio b. Ann Oncol. 1991 Oct;2(9):687-8. doi: 10.1093/oxfordjournals.annonc.a058050. Ann Oncol. 1991. PMID: 1742225 Free article.
Bone marrow biopsy in the staging of small cell lung cancer.
Franciosi V, Bisagni G, Ceci G, Boni C, De Lisi V, Di Blasio B, Lottici R, Passalacqua R, Cocconi G. Franciosi V, et al. Among authors: di blasio b. Tumori. 1989 Dec 31;75(6):576-9. doi: 10.1177/030089168907500612. Tumori. 1989. PMID: 2559525 Review.
97 results